Results 11 to 20 of about 1,026,086 (312)

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement [PDF]

Baylor University Medical Center Proceedings, 2020
Transcatheter aortic valve replacement (TAVR) valve-in-valve (VIV) therapy has been approved for select patients with surgically inoperable bioprosthetic valves that need replacement. Bioprosthetic valve fracturing (BVF) used in conjunction with VIV TAVR can reduce transvalvular gradients and increase the aortic valve area.
Mohanad Hamandi, Ikenna Nwafor, Katherine R. Hebeler, Alexander Crawford, Allison T. Lanfear, Justin Schaffer, Karim Al-Azizi, Srinivasa Potluri, William T. Brinkman, Katherine Harrington, Molly Szerlip, J. Michael DiMaio   +11 more
openaire   +2 more sources

Valve in Valve [PDF]

Circulation, 2012
The first mechanical heart valve prosthesis, designed by Dr Charles Hufnagel, was implanted to the descending aorta of a 30-year-old woman with severe aortic regurgitation in 1952.1 Eight years after the initial successful prosthetic valve implantation, Dr Harken sutured a prosthetic valve (Starr Edwards Valve) to the aortic annulus after removing the ...
E Murat, Tuzcu, Samir R, Kapadia, Lars G, Svensson   +2 more
openaire   +2 more sources

Failed valve-in-valve transcatheter mitral valve implantation [PDF]

European Journal of Cardio-Thoracic Surgery, 2014
A 73-year old man underwent trans-septal anterograde implantation of a 26-mm Sapien-XT valve (Edwards Lifesciences, CA, USA) to treat a degenerated 27-mm Carpentier-Edwards bioprosthesis. During the follow-up, the patient experienced severe haemolysis with moderate-to-severe inter-valvular leak, and fluoroscopy revealed possible incomplete apposition ...
Giuseppe, Bruschi, Luca, Botta, Pasquale, Fratto, Luigi, Martinelli   +3 more
openaire   +2 more sources

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

The American Journal of Cardiology, 2022
The use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is increasing, but studies evaluating clinical outcomes in these patients are scarce. Also, there are limited data to guide the choice of valve type in ViV-TAVI. Therefore, this CENTER-study evaluated clinical outcomes in patients with ViV-TAVI compared to patients with native
Astrid C. van Nieuwkerk, Raquel B. Santos, Eduard Fernandez-Nofrerias, Didier Tchétché, Fabio S. de Brito, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio, Flavio Ribichini, Vicente Mainar, Nicolas Dumonteil, Jan Baan, Alexandre Abizaid, Samantha Sartori, Paola D'Errigo, Giuseppe Tarantini, Mattia Lunardi, Katia Orvin, Matteo Pagnesi, Garikoitz Lasa Larraya, Angie Ghattas, George Dangas, Roxana Mehran, Ronak Delewi   +24 more
openaire   +6 more sources

Transfemoral transcatheter valve-in-valve-in-valve replacement [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2016
From the Divisions of Cardiovascular Surgery and Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Disclosures: Authors have nothing to disclose with regard to commercial support. Received for publication Dec 16, 2015; revisions received Feb 11, 2016; accepted for publicationMarch 14, 2016; available ...
Stephane, Leung Wai Sang, Jay, Giri, Prashanth, Vallabhajosyula   +2 more
openaire   +2 more sources

Valve-in-valve transcatheter mitral valve replacement procedure in prosthetic valve stenosis

IHJ Cardiovascular Case Reports (CVCR), 2023
A patient presented with acute respiratory failure and shock due to severe prosthetic mitral valve stenosis. A valve-in-valve transcatheter mitral valve replacement procedure was performed via the transeptal approach due to his high-risk presentation with good results.
Mridul Bansal, Aryan Mehta, David X. Zhao, Saraschandra Vallabhajosyula   +3 more
openaire   +3 more sources

Valve in valve and valve in ring transcatheter aortic valveimplantation

Bulgarian Cardiology, 2022
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young patients, has increased in order to avoid anticoagulant therapy. The patient’s age remains one of the leading risk factors for valve dysfunction.
P. Simeonov, B. Barzashka, D. Trendafilova, J. Jorgova, D. Petkov, P. Abedinov   +5 more
openaire   +3 more sources

Valve in Valve in Valve

JACC: Case Reports, 2019
A female patient presented with severe, symptomatic aortic stenosis after distant surgical aortic valve replacement and subsequent transcatheter aortic valve implantation 6 years prior. A 23-mm CoreValve Evolut (Medtronic, Dublin, Ireland) was implanted with excellent symptomatic and hemodynamic results. (Level of Difficulty: Advanced.).
Brian J. Grondahl, DO, Gaurav Dhar, MD
openaire   +3 more sources

Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundIn aortic stenosis (AS), symptoms and left ventricular (LV) dysfunction represent a later disease state, and objective parameters that identify incipient LV dysfunction are needed.
Andrew Goodman, Kenya Kusunose, Zoran B. Popovic, Roosha Parikh, Tyler Barr, Joseph F. Sabik, L. Leonardo Rodriguez, Lars G. Svensson, Brian P. Griffin, Milind Y. Desai   +9 more
doaj   +1 more source

Natural history observations in moderate aortic stenosis

BMC Cardiovascular Disorders, 2021
Background The natural history of patients with moderate aortic stenosis (AS) is poorly understood. We aimed to determine the long-term outcomes of patients with moderate AS.
Yu Du, Mario Gössl, Santiago Garcia, Maurice Enriquez-Sarano, Joao L. Cavalcante, Richard Bae, Go Hashimoto, Miho Fukui, Bernardo Lopes, Aisha Ahmed, Christian Schmidt, Larissa Stanberry, Ross Garberich, Steven M. Bradley, Robert Steffen, Paul Sorajja   +15 more
doaj   +1 more source